SPARE Trial: Scalp Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (200 kHz) for Patients With Newly Diagnosed Glioblastoma

Authors
Category Primary study
JournalInternational Journal of Radiation Oncology Biology Physics
Year 2021
This article has no abstract
Epistemonikos ID: 2c479dfdd96a90ac3d734bcc64ac8da948a8a27f
First added on: Dec 20, 2022